Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by CrAyZeon Jul 21, 2015 2:58pm

304 Views

Post# 23945714

Update

Good Morning Dan,

Thank you for the email and the welcome. I am excited to be a part of the team at this fantastic juncture in the company’s business model. It truly is an exciting time right now.

Yes, we do anticipate a July approval as we are well past the 60 day guideline we received from Health Canada. But I should also stress that with any government regulatory body, we are at their mercy as far as when they complete our approval. We have not received any guidance from them as to outstanding issues or concerns they may have and so expect approval any day now. But we wait patiently for it.

I hope you have a great day and feel free to reach out to me via email or phone any time.

Best Regards,

Michael Borovec
Director, Investor Relations
Theralase Technologies Inc.
Office: 416.699.5273 x222
Mobile: 647.230.5330 x222
Fax: 416.699.5250
mborovec@theralase.com
www.theralase.com

Bullboard Posts

Eminent acquires promising Nevada gold project